Back to Search
CELESTE BELLO, MD
MD
Hematology & Oncology Physician
NPI: 1942364856IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME93405(FL)
Education
UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Class of 2002
Research & Publications (20)
Monoclonal antibodies for B-cell lymphomas: rituximab and beyond.
PMID 18024635·Hematology Am Soc Hematol Educ Program·2007
6-review
A short and convenient synthesis of 1-deoxymannojirimycin and N-oxy analogues from D-fructose.
PMID 19152266·J Org Chem·2009
8-other
Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
PMID 19262940·Org Biomol Chem·2009
8-other
Design and synthesis of acetamido tri- and tetra-hydroxyazepanes: potent and selective beta-N-acetylhexosaminidase inhibitors.
PMID 19592259·Bioorg Med Chem·2009
7-preclinical
Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species.
PMID 19169880·Cancer Chemother Pharmacol·2009
7-preclinical
Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial.
PMID 19142552·Clinics (Sao Paulo)·2009
2-rct
A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients.
PMID 19258444·Clin Cancer Res·2009
1-meta
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
PMID 18347007·J Clin Oncol·2008
3-trial
Comparison of 4 laboratory methods for detection of Helicobacter pylori.
PMID 18382793·Saudi Med J·2008
4-observational
Modern approaches to treating chronic myelogenous leukemia.
PMID 18706263·Curr Oncol Rep·2008
6-review
Identification and quantification of phenolic compounds in grapes by HPLC-PDA-ESI-MS on a semimicro separation scale.
PMID 18781764·J Agric Food Chem·2008
8-other
Sex differences in the clinical presentation of urban Nigerian patients with pulmonary tuberculosis.
PMID 19025020·West Afr J Med·2008
4-observational
A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period.
PMID 17505827·Cancer Chemother Pharmacol·2008
3-trial
New synthetic seven-membered 1-azasugars displaying potent inhibition towards glycosidases and glucosylceramide transferase.
PMID 18188862·Chembiochem·2008
8-other
Clinical presentation of adults with pulmonary tuberculosis with and without HIV infection in Nigeria.
PMID 17852913·Scand J Infect Dis·2008
4-observational
Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.
PMID 17473195·Clin Cancer Res·2007
3-trial
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins.
PMID 17605814·J Transl Med·2007
3-trial
Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib.
PMID 17761718·Ann Oncol·2007
6-review
Human pulmonary infections with bovine and environment (atypical) mycobacteria in jos, Nigeria.
PMID 17496986·Ghana Med J·2006
8-other
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
PMID 17046465·Lancet·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12901 USF MAGNOLIA DR
TAMPA, FL 33612 - Phone
- (813) 745-4673
Quick Facts
- NPI
- 1942364856
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile